Clinical Trial Update: Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing the antiplatelet effects of ticagrelor vs tirofiban in patients with non-ST-elevation acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)
• tirofiban (tirofiban)

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Non-ST Segment Elevation Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN